The LW group recruited various metabolic pathways (such as ketone body metabolism) that have the potential to increase tumour cell activity (i.e., enhancing Ki-67 and mTOR expression), however, the nutritional supplementation did not appear to benefit tumour growth (Fig. 5). The gene discussed is MTOR; the disease is neoplasm.